MyFinsight
Home
Blog
About
Cash and cash
equivalents, at carrying...
$2,229K
(-35.69%↓ Y/Y)
Prepaid expense,
current
$1,372K
(-18.48%↓ Y/Y)
Other assets, current
$111K
(76.19%↑ Y/Y)
Restricted cash and cash
equivalents, current
$29K
(16.00%↑ Y/Y)
Operating lease,
right-of-use asset
$348K
(-26.27%↓ Y/Y)
Deposits assets,
noncurrent
$75K
(1400.00%↑ Y/Y)
Restricted cash,
noncurrent
$62K
(16.98%↑ Y/Y)
Property, plant and
equipment, net
$20K
(-33.33%↓ Y/Y)
Assets, current
$3,741K
(-28.57%↓ Y/Y)
Assets, noncurrent
$505K
(-9.82%↓ Y/Y)
Assets
$4,246K
(-26.76%↓ Y/Y)
Liabilities and equity
$4,246K
(-26.76%↓ Y/Y)
Liabilities
$4,202K
(-25.98%↓ Y/Y)
Equity, attributable to
parent
$44K
(-63.33%↓ Y/Y)
Retained earnings
(accumulated deficit)
-$61,450K
(-29.39%↓ Y/Y)
Liabilities, current
$3,976K
(84.93%↑ Y/Y)
Liabilities, noncurrent
$226K
(-93.59%↓ Y/Y)
Additional paid in capital
$61,334K
(28.84%↑ Y/Y)
Common stock, value,
issued
$160K
(1900.00%↑ Y/Y)
Accounts payable, trade,
current
$1,180K
Represent the amount of
related party...
$985K
Accounts payable, other,
current
$984K
Employee-related liabilities,
current
$628K
(0.00%↑ Y/Y)
Operating lease,
liability, current
$199K
(16.37%↑ Y/Y)
Operating lease,
liability, noncurrent
$226K
(-32.94%↓ Y/Y)
Back
Back
Balance Sheet
Silexion Therapeutics Corp (SLXNW)
Silexion Therapeutics Corp (SLXNW)
source: myfinsight.com